Lysophosphatidic acid production and action: Critical new players in breast cancer initiation and progression

N. Panupinthu, H. Y. Lee, Gordon Mills

Research output: Contribution to journalShort survey

80 Citations (Scopus)

Abstract

Lysophosphatidic acid (LPA) is a potent lipid mediator that acts on a series of specific G protein-coupled receptors, leading to diverse biological actions. Lysophosphatidic acid induces cell proliferation, survival and migration, which are critically required for tumour formation and metastasis. This bioactive lipid is produced by the ectoenzyme lysophospholipase D or autotaxin (ATX), earlier known as an autocrine motility factor. The ATX-LPA signalling axis has emerged as an important player in many types of cancer. Indeed, aberrant expression of ATX and LPA receptors occurs during the development and progression of breast cancer. Importantly, expression of either ATX or LPA receptors in the mammary gland of transgenic mice is sufficient to induce the development of a high frequency of invasive and metastatic mammary cancers. The focus of research now turns to understanding the mechanisms by which ATX and LPA promote mammary tumourigenesis and metastasis. Targeting the ATX-LPA signalling axis for drug development may further improve outcomes in patients with breast cancer.

Original languageEnglish (US)
Pages (from-to)941-946
Number of pages6
JournalBritish Journal of Cancer
Volume102
Issue number6
DOIs
StatePublished - Mar 1 2010
Externally publishedYes

Fingerprint

Breast Neoplasms
Lysophosphatidic Acid Receptors
Neoplasm Metastasis
Glucose-6-Phosphate Isomerase
Lipids
Human Mammary Glands
G-Protein-Coupled Receptors
Transgenic Mice
Cell Movement
Neoplasms
Cell Survival
Breast
Cell Proliferation
lysophosphatidic acid
Research
Pharmaceutical Preparations

Keywords

  • Autotaxin
  • Breast cancer
  • G protein-coupled receptor
  • Inflammation
  • Lysophosphatidic acid

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Lysophosphatidic acid production and action : Critical new players in breast cancer initiation and progression. / Panupinthu, N.; Lee, H. Y.; Mills, Gordon.

In: British Journal of Cancer, Vol. 102, No. 6, 01.03.2010, p. 941-946.

Research output: Contribution to journalShort survey

@article{cdb0780e857a4fef877b0a1e7d2a2696,
title = "Lysophosphatidic acid production and action: Critical new players in breast cancer initiation and progression",
abstract = "Lysophosphatidic acid (LPA) is a potent lipid mediator that acts on a series of specific G protein-coupled receptors, leading to diverse biological actions. Lysophosphatidic acid induces cell proliferation, survival and migration, which are critically required for tumour formation and metastasis. This bioactive lipid is produced by the ectoenzyme lysophospholipase D or autotaxin (ATX), earlier known as an autocrine motility factor. The ATX-LPA signalling axis has emerged as an important player in many types of cancer. Indeed, aberrant expression of ATX and LPA receptors occurs during the development and progression of breast cancer. Importantly, expression of either ATX or LPA receptors in the mammary gland of transgenic mice is sufficient to induce the development of a high frequency of invasive and metastatic mammary cancers. The focus of research now turns to understanding the mechanisms by which ATX and LPA promote mammary tumourigenesis and metastasis. Targeting the ATX-LPA signalling axis for drug development may further improve outcomes in patients with breast cancer.",
keywords = "Autotaxin, Breast cancer, G protein-coupled receptor, Inflammation, Lysophosphatidic acid",
author = "N. Panupinthu and Lee, {H. Y.} and Gordon Mills",
year = "2010",
month = "3",
day = "1",
doi = "10.1038/sj.bjc.6605588",
language = "English (US)",
volume = "102",
pages = "941--946",
journal = "British Journal of Cancer",
issn = "0007-0920",
publisher = "Nature Publishing Group",
number = "6",

}

TY - JOUR

T1 - Lysophosphatidic acid production and action

T2 - Critical new players in breast cancer initiation and progression

AU - Panupinthu, N.

AU - Lee, H. Y.

AU - Mills, Gordon

PY - 2010/3/1

Y1 - 2010/3/1

N2 - Lysophosphatidic acid (LPA) is a potent lipid mediator that acts on a series of specific G protein-coupled receptors, leading to diverse biological actions. Lysophosphatidic acid induces cell proliferation, survival and migration, which are critically required for tumour formation and metastasis. This bioactive lipid is produced by the ectoenzyme lysophospholipase D or autotaxin (ATX), earlier known as an autocrine motility factor. The ATX-LPA signalling axis has emerged as an important player in many types of cancer. Indeed, aberrant expression of ATX and LPA receptors occurs during the development and progression of breast cancer. Importantly, expression of either ATX or LPA receptors in the mammary gland of transgenic mice is sufficient to induce the development of a high frequency of invasive and metastatic mammary cancers. The focus of research now turns to understanding the mechanisms by which ATX and LPA promote mammary tumourigenesis and metastasis. Targeting the ATX-LPA signalling axis for drug development may further improve outcomes in patients with breast cancer.

AB - Lysophosphatidic acid (LPA) is a potent lipid mediator that acts on a series of specific G protein-coupled receptors, leading to diverse biological actions. Lysophosphatidic acid induces cell proliferation, survival and migration, which are critically required for tumour formation and metastasis. This bioactive lipid is produced by the ectoenzyme lysophospholipase D or autotaxin (ATX), earlier known as an autocrine motility factor. The ATX-LPA signalling axis has emerged as an important player in many types of cancer. Indeed, aberrant expression of ATX and LPA receptors occurs during the development and progression of breast cancer. Importantly, expression of either ATX or LPA receptors in the mammary gland of transgenic mice is sufficient to induce the development of a high frequency of invasive and metastatic mammary cancers. The focus of research now turns to understanding the mechanisms by which ATX and LPA promote mammary tumourigenesis and metastasis. Targeting the ATX-LPA signalling axis for drug development may further improve outcomes in patients with breast cancer.

KW - Autotaxin

KW - Breast cancer

KW - G protein-coupled receptor

KW - Inflammation

KW - Lysophosphatidic acid

UR - http://www.scopus.com/inward/record.url?scp=77949504534&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77949504534&partnerID=8YFLogxK

U2 - 10.1038/sj.bjc.6605588

DO - 10.1038/sj.bjc.6605588

M3 - Short survey

C2 - 20234370

AN - SCOPUS:77949504534

VL - 102

SP - 941

EP - 946

JO - British Journal of Cancer

JF - British Journal of Cancer

SN - 0007-0920

IS - 6

ER -